M Bandera1, M Fioretti, R Rimoldi
1Pneumology Dept., Ospedale Civile, Varese, Italy.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Roxithromycin, a new macrolide antibiotic, does not significantly alter theophylline plasma levels in patients with chronic bronchitis. This finding suggests that roxithromycin can be safely co-administered with controlled-release theophylline formulations.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: